
Background This study aimed to explore the determinants and pathways of fatigue in older adult patients with stroke, drawing upon the theory of unpleasant symptoms, to inform clinical interventions. Methods A convenience sampling method was used to recruit 234 older adult patients with stroke between July 2024 and January 2025. Data were collected using the Multidimensional Fatigue Inventory, Hospital Anxiety and Depression Scale, Pittsburgh Sleep Quality Index, Social Support Rating Scale, and Stroke Specific Quality of Life Scale. Statistical analysis was conducted using R software (version 4.4.3), and a structural equation model was constructed. The mediating effect was evaluated using the Bootstrap method. Results Fatigue levels were significantly higher in patients with greater anxiety, depression, poorer sleep quality, and higher C-reactive protein (CRP) levels, and in those with lower education level and poorer stroke-specific quality of life (all p < 0.05). The structural equation model demonstrated a good fit (CFI = 1.000, RMSEA = 0.000). Anxiety, depression, and sleep quality were identified as complete mediators between education level, social support, CRP levels, and fatigue. The mediating effect accounted for 70.1 of the total effect, indicating that anxiety, depression, and sleep quality collectively explain most of the association between sociodemographic, psychosocial, and inflammatory factors and fatigue in this population. Conclusion Fatigue among older adult patients with stroke is influenced by multiple interrelated factors, with anxiety, depression, and sleep quality acting as key mediators. These findings support routine screening and targeted management of psychological distress and sleep problems to mitigate fatigue during stroke rehabilitation.
BackgroundVitamin D deficiency is prevalent in patients with chronic myofascial pain syndrome (MPS) and has been proposed as a potential medical precipitating factor. However, no clinical trials have compared different vitamin D supplementation doses in patients with chronic MPS and vitamin D deficiency.ObjectivesThis study aimed to compare the effects of weekly ergocalciferol 40,000 IU (standard dose) and 80,000 IU (high dose) on serum 25(OH)D levels and clinically meaningful pain reduction.MethodsIn this randomized, single-blind, active-controlled trial, 70 patients were randomly assigned to receive high-dose (n = 35) or standard-dose (n = 35) ergocalciferol for 8 weeks. The primary outcome was the proportion achieving optimal serum 25(OH)D (≥30 ng/mL). Secondary outcomes included ≥30% pain reduction and symptomatic adverse effects. Multiple imputation was used to handle missing data.ResultsAt week 8, mean serum 25(OH)D was higher in the high-dose group than in the standard-dose group (46.6 ng/mL; 95% CI, 40.6-52.7 vs. 34.4 ng/mL; 95% CI, 30.9-37.9). However, the high-dose regimen did not significantly increase the odds of achieving optimal serum 25(OH)D (aOR, 3.23; 95% CI, 0.77-13.42) or ≥30% pain reduction (aOR, 1.17; 95% CI, 0.33-4.10). Clinically meaningful pain reduction occurred in 75.8% and 66.7% of the high- and standard-dose groups, respectively. No symptomatic adverse effects were reported in either group.ConclusionAlthough the 80,000-IU weekly regimen resulted in higher serum 25(OH)D levels, it did not demonstrate a significant advantage over the 40,000-IU weekly regimen in achieving optimal vitamin D status or clinically meaningful pain reduction after 8 weeks.
BackgroundPadel is a growing sport in Saudi Arabia; however, data on related musculoskeletal injuries and associated factors are limited. The increasing number of players highlights the importance of understanding padel-related injury patterns and their associated characteristics.ObjectiveTo describe self-reported musculoskeletal injury patterns among surveyed padel players in Saudi Arabia and examine player-, exposure-, equipment-, and injury-related characteristics associated with anatomical injury location among reported injury cases.MethodA cross-sectional study was conducted using a self-administered questionnaire distributed through convenience and snowball sampling to padel players in Saudi Arabia between February and March 2025. The questionnaire collected information on demographic characteristics, playing exposure, equipment characteristics, injury history, and injury-related characteristics.ResultsA total of 600 padel players were included in the analysis, of whom 301 reported at least one padel-related musculoskeletal injury, corresponding to 50.2% of the surveyed sample, with 513 reported injury cases. Upper-quadrant injuries were the most frequently reported (44.1%), followed by foot/ankle (22.4%), spine (18.5%), and knee injuries (15.0%). In multivariable GEE analyses of reported injury observations, weekly playing hours were associated with foot/ankle and knee injury classification. Other significant associations with anatomical injury classification involved ADL limitation, pain severity, recovery duration, recurrence, sex, padel education, and racket hardness, with patterns varying by anatomical location.ConclusionThese findings characterize self-reported musculoskeletal injury patterns among surveyed padel players and identify characteristics associated with anatomical injury location. Prospective studies are needed to determine factors associated with subsequent injury occurrence and to inform targeted preventive strategies.
Purpose Lateral epicondylitis (LE) is often associated with myofascial trigger points (MTrPs) in the forearm extensor muscles. Although dry needling (DN) is commonly performed using palpation-guided techniques without real-time imaging, its anatomical accuracy remains unclear. This study evaluated the accuracy of palpation-guided DN targeting the extensor digitorum communis (EDC), extensor carpi radialis brevis (ECRB), extensor carpi radialis longus (ECRL), and brachioradialis (BR) using ultrasound verification. Methods Thirty-nine patients with MRI-confirmed LE and active MTrPs underwent palpation-guided DN targeting the most symptomatic muscle identified by algometry. Ultrasound verified algometer position during target selection but did not guide needle insertion. An independent sonographer blinded to the intended target verified needle-tip location. Accuracy was compared using Fisher's exact test with Bonferroni correction. Results Accuracy was BR 10/10 (100%; 95% CI 69.2–100.0%), EDC 10/10 (100%; 69.2–100.0%), ECRB 7/9 (77.8%; 40.0–97.2%), and ECRL 1/10 (10%; 0.3–44.5%). After Bonferroni correction for six pairwise comparisons, ECRL accuracy was significantly lower than BR (adjusted p < 0.001), EDC (adjusted p < 0.001), and ECRB (adjusted p = 0.033). Most ECRL misplacements entered ECRB (7/9) or EDC (2/9). No identifiable neurovascular structure was penetrated during immediate ultrasound verification; procedural safety was not established. Conclusion Anatomical accuracy varied by target muscle in this small, single-operator study. ECRL showed particularly low observed accuracy. Ultrasound guidance may improve anatomical precision when targeting ECRL, but larger multi-operator studies are needed to confirm these findings and determine their clinical relevance.
Background Evidence on capacitive-resistive electric transfer (TECAR) applied concurrently with exercise in subacute lateral ankle sprain (LAS) is limited. Objective To evaluate the short-term effects of adding concurrent TECAR to exercise in subacute LAS. Methods Forty-two participants (20–40 years) with grade I-II LAS (10–21 days post-injury) were randomly allocated to exercise plus concurrent TECAR (EG; n = 21) or exercise alone (CG; n = 21). Both groups completed identical 20-min supervised sessions twice weekly for six weeks; TECAR did not extend session duration. Co-primary outcomes were pain (Numeric Pain Rating Scale; NPRS) and Y-Balance Test (YBT) composite score ( α = 0.025). Secondary outcomes were joint position error (JPE) and Foot and Ankle Ability Measure (FAAM). Results All 42 randomized participants were analyzed; both groups improved on all outcomes ( p < 0.001). Versus exercise alone, TECAR was associated with greater improvements in pain (MD = 1.60, 95% CI 0.84–2.36, p < 0.001; below the 2-point minimal clinically important difference [MCID]), YBT composite (MD = 5.29%, 95% CI 1.44–9.14, p = 0.009), JPE (MD = 2.58°, 95% CI 2.03–3.13, p < 0.001), FAAM-ADL (MD = 10.39, 95% CI 7.72–13.06, p < 0.001), and FAAM-Sports (MD = 13.24, 95% CI 8.50–17.98, p < 0.001). Directional YBT differences did not survive multiplicity correction. Conclusion Adding TECAR was associated with greater short-term improvements in pain, sensorimotor performance, proprioception, and function in subacute LAS. However, the additional pain reduction was below the MCID. Without a sham control, findings reflect clinical effectiveness rather than modality-specific efficacy.